Wells Fargo
LUCD icon

Wells Fargo’s Lucid Diagnostics LUCD Stock Holding History

Wells Fargo’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
2,067,046
+792,656
+62% +$854K ﹤0.01% 3506
2026
Q1 		$1.47M Buy
1,274,390
+354,911
+39% +$452K ﹤0.01% 3505
2025
Q4 		$1M Buy
919,479
+205,166
+29% +$229K ﹤0.01% 3970
2025
Q3 		$721K Buy
714,313
+487,453
+215% +$532K ﹤0.01% 4043
2025
Q2 		$261K Buy
226,860
+224,710
+10,452% +$290K ﹤0.01% 4611
2025
Q1 		$3.2K Sell
2,150
-150
-7% -$180 ﹤0.01% 6095
2024
Q4 		$1.88K Sell
2,300
-163
-7% -$144 ﹤0.01% 6196
2024
Q3 		$2.01K Sell
2,463
-1,000
-29% -$819 ﹤0.01% 6055
2024
Q2 		$2.84K Sell
3,463
-11,042
-76% -$9.36K ﹤0.01% 5963
2024
Q1 		$11.7K Buy
14,505
+5,424
+60% +$7.04K ﹤0.01% 5713
2023
Q4 		$12.8K Buy
9,081
+4
+0% +$5 ﹤0.01% 5764
2023
Q3 		$10.6K Buy
9,077
+8,983
+9,556% +$13K ﹤0.01% 5795
2023
Q2 		$131 Buy
94
+35
+59% +$53 ﹤0.01% 6813
2023
Q1 		$83 Buy
59
+1
+2% +$1 ﹤0.01% 6975
2022
Q4 		$79 Buy
58
+2
+4% +$4 ﹤0.01% 6856
2022
Q3 		$0 Buy
56
+20
+56% +$50 ﹤0.01% 7072
2022
Q2 		$0 Sell
36
-1,063
-97% -$2.36K ﹤0.01% 7205
2022
Q1 		$4K Sell
1,099
-2,009
-65% -$7.34K ﹤0.01% 6529
2021
Q4 		$16K Buy
+3,108
New +$25.2K ﹤0.01% 6399

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Wells Fargo's LUCD Position: Q2 2026 in Review

Wells Fargo increased its Lucid Diagnostics (LUCD) stake by 62% in Q2 2026, buying an estimated $854K and bringing the position to 2,067,046 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3506.

Wells Fargo first reported a position in LUCD in Q4 2021 and has held it in 19 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Wells Fargo held 2,067,046 shares of Lucid Diagnostics worth $2.21M as of Q2 2026.
  • Wells Fargo bought 792,656 Lucid Diagnostics shares in Q2 2026, an estimated $854K.
  • Lucid Diagnostics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3506 holding.
  • Wells Fargo first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.